Adaptimmune Therapeutics PLC (ADAP)
0.233
-0.02
(-6.80%)
USD |
NASDAQ |
Mar 26, 13:32
Adaptimmune Therapeutics Market Cap: 59.94M for March 26, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
TC BioPharm (Holdings) PLC | 0.1231M |
Biodexa Pharmaceuticals PLC | 1.023M |
Autolus Therapeutics PLC | 425.81M |
Bicycle Therapeutics PLC | 599.98M |
Verona Pharma PLC | 5.524B |
Market Cap Related Metrics
PS Ratio | 0.3316 |
Price to Book Value | 5.058 |
Price | 0.233 |
Earnings Yield | -134.6% |